logo-loader
viewAvacta Group PLC

Riccardo Lowi discusses Avacta

Riccardo lowi discusses Avacta's good progress on both the Affimer therapeutics and reagents programs.

Quick facts: Avacta Group PLC

Price: 43 GBX

AIM:AVCT
Market: AIM
Market Cap: £75.7 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

AzurRx reveals most recent advancements in its gastrointestinal disorder...

AzurRx BioPharma, Inc. (NASDAQ:AZRX) CEO James Sapirstein tells Proactive the New York-based biotechnology company how its advancing its treatment of patients with gastrointestinal disorders. Sapirstein, who has helped to raise more than $6.9 million for the company, says he's not concerned...

1 minute ago

2 min read